全文获取类型
收费全文 | 166177篇 |
免费 | 9652篇 |
国内免费 | 1877篇 |
专业分类
耳鼻咽喉 | 2432篇 |
儿科学 | 4727篇 |
妇产科学 | 3312篇 |
基础医学 | 20845篇 |
口腔科学 | 5148篇 |
临床医学 | 12439篇 |
内科学 | 37221篇 |
皮肤病学 | 4699篇 |
神经病学 | 12176篇 |
特种医学 | 4032篇 |
外国民族医学 | 3篇 |
外科学 | 19662篇 |
综合类 | 6609篇 |
现状与发展 | 17篇 |
一般理论 | 61篇 |
预防医学 | 16412篇 |
眼科学 | 3924篇 |
药学 | 12988篇 |
54篇 | |
中国医学 | 3073篇 |
肿瘤学 | 7872篇 |
出版年
2023年 | 1321篇 |
2022年 | 1918篇 |
2021年 | 4378篇 |
2020年 | 2781篇 |
2019年 | 4059篇 |
2018年 | 6364篇 |
2017年 | 4254篇 |
2016年 | 3887篇 |
2015年 | 4623篇 |
2014年 | 5318篇 |
2013年 | 7290篇 |
2012年 | 12297篇 |
2011年 | 12992篇 |
2010年 | 7220篇 |
2009年 | 5375篇 |
2008年 | 10254篇 |
2007年 | 10681篇 |
2006年 | 9814篇 |
2005年 | 9549篇 |
2004年 | 8175篇 |
2003年 | 7723篇 |
2002年 | 7139篇 |
2001年 | 4345篇 |
2000年 | 4926篇 |
1999年 | 3701篇 |
1998年 | 804篇 |
1997年 | 550篇 |
1996年 | 504篇 |
1995年 | 424篇 |
1994年 | 409篇 |
1993年 | 298篇 |
1992年 | 1533篇 |
1991年 | 1358篇 |
1990年 | 1192篇 |
1989年 | 987篇 |
1988年 | 842篇 |
1987年 | 820篇 |
1986年 | 822篇 |
1985年 | 685篇 |
1984年 | 488篇 |
1983年 | 374篇 |
1979年 | 362篇 |
1975年 | 292篇 |
1974年 | 334篇 |
1973年 | 372篇 |
1972年 | 308篇 |
1971年 | 320篇 |
1970年 | 308篇 |
1969年 | 317篇 |
1968年 | 296篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 探讨低危单胎的足月妊娠自然临产后,潜伏期脑胎盘率(CPR)对预测新生儿不良结局的价值。方法 选取2018年1月至2021年3月我院住院临产分娩的673例孕妇为研究对象,测量胎儿大脑中动脉、脐动脉血流参数,获得分娩结局及新生儿结局。参考既往研究得出的不同孕周CPR正常参考值百分位作为分组指标(CPR≤10%参考值定为低CPR)。比较低CPR组(72例)与正常CPR组(601例)两组妊娠结局、新生儿不良结局。结果 低CPR组与正常CPR组在孕妇年龄、孕龄、产次、孕期体质量增长、总产程、新生儿体质量的构成上差异均无统计学意义(P>0.05)。低CPR组因胎儿窘迫行剖宫产或助产发生率、新生儿任一不良结局发生率、新生儿不良结局率均高于正常CPR组,差异均有统计学意义(P<0.05)。低CPR预测新生儿不良结局的准确率为89.5%(602/673),敏感度为51.7%(15/29),特异度为91.1%(587/644)。结论 本研究数据显示,对于无并发症及合并症、低风险的单胎足月妊娠,潜伏期低CPR与新生儿不良结局相关。 相似文献
3.
Vilar-Compte Mireya Gaitán-Rossi Pablo Félix-Beltrán Lucía Bustamante Arturo V. 《Journal of immigrant and minority health / Center for Minority Public Health》2022,24(1):65-77
Journal of Immigrant and Minority Health - COVID-19 has disproportionally affected underrepresented minorities (URM) and low-income immigrants in the United States. The aim of the study is to... 相似文献
4.
5.
6.
7.
Ali Mobasheri Csaba Matta Ilona Uzielienè Emma Budd Pablo Martín-Vasallo Eiva Bernotiene 《Joint, bone, spine : revue du rhumatisme》2019,86(1):29-35
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development. 相似文献
8.
9.
Jose M. Morales Jose Angel Martinez-Flores Manuel Serrano Maria José Castro Francisco Javier Alfaro Florencio García Miguel Angel Martínez Amado Andrés Esther González Manuel Praga Estela Paz-Artal Antonio Serrano 《Journal of the American Society of Nephrology : JASN》2015,26(3):735-745
In the current immunosuppressive therapy era, vessel thrombosis is the most common cause of early graft loss after renal transplantation. The prevalence of IgA anti–β2-glycoprotein I antibodies (IgA-aB2GPI-ab) in patients on dialysis is elevated (>30%), and these antibodies correlate with mortality and cardiovascular morbidity. To evaluate the effect of IgA-aB2GPI-ab in patients with transplants, we followed all patients transplanted from 2000 to 2002 in the Hospital 12 de Octubre prospectively for 10 years. Presence of IgA-aB2GPI-ab in pretransplant serum was examined retrospectively. Of 269 patients, 89 patients were positive for IgA-aB2GPI-ab (33%; group 1), and the remaining patients were negative (67%; group 2). Graft loss at 6 months post-transplant was significantly higher in group 1 (10 of 89 versus 3 of 180 patients in group 2; P=0.002). The most frequent cause of graft loss was thrombosis of the vessels, which was observed only in group 1 (8 of 10 versus 0 of 3 patients in group 2; P=0.04). Multivariate analysis showed that the presence of IgA-aB2GPI-ab was an independent risk factor for early graft loss (P=0.04) and delayed graft function (P=0.04). There were no significant differences regarding patient survival between the two groups. Graft survival was similar in both groups after 6 months. In conclusion, patients with pretransplant IgA-aB2GPI-ab have a high risk of early graft loss caused by thrombosis and a high risk of delayed graft function. Therefore, pretransplant IgA-aB2GPI-ab may have a detrimental effect on early clinical outcomes after renal transplantation. 相似文献